18th week of 2013 patent applcation highlights part 43

Patent application number	Title	Published
18th week of 2013 patent applcation highlights part 43
20130108544	SCR CATALYSTS PREPARATION METHODS	2013-05-02
20130108545	SYNTHESIS OF A CRYSTALLINE SILICOALUMINOPHOSPHATE	2013-05-02
20130108546	Humanized Antibodies That Recognize Alpha-Synuclein	2013-05-02
20130108547	Recombinantly Produced Antibodies Targeting ErbB Signaling Molecules and Methods of Use Thereof for the Diagnosis and Treatment of Disease	2013-05-02
20130108548	PEPTIDE DERIVATIVES, PREPARATION AND USES THEREOF	2013-05-02
20130108549	PEPTIDE PROBES FOR DIAGNOSTICS AND THERAPEUTICS	2013-05-02
20130108550	Bioabsorbable Co-Filler for Cerebrovascular Aneurysms	2013-05-02
20130108551	LIPID BILAYER CARRIER FOR DRUGS OR IMAGING AGENTS	2013-05-02
20130108552	NEAR-IR INDOCYANINE GREEN DOPED MULTIMODAL SILICA NANOPARTICLES AND METHODS FOR MAKING THE SAME	2013-05-02
20130108553	Metal Mixes For Use In Epicutaneous Patch Test	2013-05-02
20130108554	CONTRAST AGENTS	2013-05-02
20130108555	Compositions for visualization of cleaning efficacy and product coverage	2013-05-02
20130108556	PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION OF A MEDICAMENT	2013-05-02
20130108557	COSMETIC FOAM	2013-05-02
20130108558	FORMULATION COMPRISING NICOTINE AND A CATION EXCHANGE RESIN	2013-05-02
20130108559	Hydrogen Peroxide Toothpaste With Improved Stability	2013-05-02
20130108560	Chemical Treatments for the Disruption of Dental Plaque Biofilms and Related Methods	2013-05-02
20130108561	COMPOSITIONS FOR IMPROVING THE ORAL HEALTH OF ANIMALS, METHODS USING THE SAME, AND PET TREATS INCORPORATING THE SAME	2013-05-02
20130108562	Cosmetic Composition Containing Oligopeptides	2013-05-02
20130108563	COMPOSITIONS COMPRISING AT LEAST ONE AQUEOUS PHASE AND AT LEAST ONE FATTY PHASE WHICH COMPRISES AVERMECTIN COMPOUNDS	2013-05-02
20130108565	TANNING ENHANCERS AND SELF-TANNING SUBSTANCES	2013-05-02
20130108566	SKIN CONDITIONING COMPOSITIONS CONTAINING 12-HYDROXYSTEARIC ACID	2013-05-02
20130108567	SKIN-WHITENING COMPOSITION FOR EXTERNAL APPLICATION ON SKIN CONTAINING EXTRACTS FROM PAPER MULBERRY FLOWERS AND FRUITS	2013-05-02
20130108568	XANTHENEDIONE DERIVATIVES FOR THE TREATMENT OF PIGMENTATION AND SKIN AGEING DISORDERS	2013-05-02
20130108569	PIGMENT MIXTURE, AND USE THEREOF IN COSMETICS, FOOD AND PHARMACEUTICALS	2013-05-02
20130108570	Antiperspirant Soft Solid Compositions Comprising A Wax Blend	2013-05-02
20130108571	NOVEL AGENT FOR IMPROVING THE DEPOSITION OF OIL ON HAIR	2013-05-02
20130108572	COSMETIC OR DERMATOLOGICAL PREPARATION FOR APPLICATION ON WET SKIN	2013-05-02
20130108573	Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease	2013-05-02
20130108574	RADIOPAQUE, NON-BIODEGRADABLE, WATER-INSOLUBLE IODINATED BENZYL ETHERS OF POLY(VINYL ALCOHOL), PREPARATION METHOD THEREOF, INJECTABLE EMBOLIZING COMPOSITIONS CONTAINING THEREOF AND USE THEREOF	2013-05-02
20130108575	ANTIBACTERIAL AND ANTIFUNGAL PEPTIDES	2013-05-02
20130108576	STABLE ANTISEPTIC COMPOSITIONS AND METHODS	2013-05-02
20130108577	Method for Preparing An Optimum Density Termite Bait Composition	2013-05-02
20130108578	APO-2 LIGAND VARIANTS AND USES THEREOF	2013-05-02
20130108579	METHODS OF USING SMALL COMPOUNDS TO ENHANCE MYELOID DERIVED SUPPRESSOR CELL FUNCTION FOR TREATING AUTOIMMUNE DISEASES	2013-05-02
20130108580	FUSION PROTEIN AND ITS USES	2013-05-02
20130108581	Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic Agents	2013-05-02
20130108582	METHODS OF USE OF CYCLOPAMINE ANALOGS	2013-05-02
20130108583	METHODS OF USE FOR CYCLOPAMINE ANALOGS	2013-05-02
20130108584	RECOMBINANT VECTOR FOR PRODUCING AND SECRETING AMINO ACID SEQUENCES OF INTEREST BY PROPIONIBACTERIA AND APPLICATIONS THEREOF	2013-05-02
20130108585	CONJUGATED LINOLEIC ACID-PRODUCING STRAINS OF PROBIOTIC BACTERIA AND USE THEREOF FOR THE PREPARATION OF A FOOD, DIETETIC OR PHARMACEUTICAL COMPOSITION	2013-05-02
20130108586	COMPOSITION AND METHOD OF DELIVERY OF L-ARABINOSE AND SELECT COMPOUNDS	2013-05-02
20130108587	METHODS AND COMPOSITIONS FOR ENHANCING STEM CELL MOBILIZATION	2013-05-02
20130108588	MULTIPOTENT STEM CELL CULTURES	2013-05-02
20130108589	Method of Producing Neurons from Stem Cells, the Neurons and Uses Thereof	2013-05-02
20130108590	METHOD FOR PRODUCING CELL SHEET	2013-05-02
20130108591	METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS	2013-05-02
20130108592	USE ADIPOSE TISSUE-DERIVED REGENERATIVE CELLS IN THE MODULATION OF INFLAMMATION IN THE PANCREAS AND IN THE KIDNEY	2013-05-02
20130108593	Mesenchymal Stem Cell Isolation And Transplantation Method And System To Be Used In A Clinical Setting	2013-05-02
20130108594	METHOD FOR EVALUATING ANGIOGENIC POTENTIAL	2013-05-02
20130108595	Use of Adipose Tissue-Derived Stromal Cells in Spinal Fusion	2013-05-02
20130108596	Chondrocyte Therapeutic Delivery System	2013-05-02
20130108597	ISOLATED PRIMATE EMBRYONIC CELLS DERIVED FROM EXTENDED BLASTOCYSTS	2013-05-02
20130108598	METHOD FOR DIAGNOSING RISK OF TYPE 1 DIABETES AND FOR PREVENTING ONSET OF TYPE 1 DIABETES	2013-05-02
20130108599	Herbal Vaginal Compositions	2013-05-02
20130108600	METABOLITES IN ANIMAL FEED	2013-05-02
20130108601	USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR REGULATING SKIN PIGMENTATION	2013-05-02
20130108602	METHODS AND USES OF NUR77 AND NUR77 AGONISTS TO MODULATE MACROPHAGES AND MONOCYTES, AND TREAT INFLAMMATION, INFLAMMATORY DISEASE AND CARDIOVASCULAR DISEASE	2013-05-02
20130108603	COLLAGEN PRODUCTION COMPOUND	2013-05-02
20130108604	Topical skin care formulations	2013-05-02
20130108605	METHOD OF AMELIORATING OXIDATIVE STRESS AND SUPPLEMENTING THE DIET	2013-05-02
20130108606	Albumin Fusion Proteins	2013-05-02
20130108607	Methods and Compositions for Treating Oxalate-Related Conditions	2013-05-02
20130108608	tRNA synthetase fragments	2013-05-02
20130108609	TRANSMEMBRANE PROSTATIC ACID PHOSPHATASE	2013-05-02
20130108610	Inhibition of Microbial Growth by Aconitase Inhibition	2013-05-02
20130108611	FRAGMENTED POLYMERIC COMPOSITIONS AND METHODS FOR THEIR USE	2013-05-02
20130108612	POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS	2013-05-02
20130108613	AMYLOID-BETA CLEARANCE	2013-05-02
20130108614	WOUND HEALING PEPTIDES AND METHODS OF USE THEREOF	2013-05-02
20130108615	Date Pit Composition For The Treatment Of Animals	2013-05-02
20130108616	DETECTION AND TREATMENT OF LRP4-ASSOCIATED NEUROTRANSMISSION DISORDERS	2013-05-02
20130108617	PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS)	2013-05-02
20130108618	METHODS AND COMPOSITIONS RELATED TO INTRACELLULAR NEUTRALIZATION BY IgG	2013-05-02
20130108619	INTRAVENOUS IMMUNOGLOBULIN PROCESSING, DIAGNOSTIC, AND TREATMENT SYSTEMS AND METHODS	2013-05-02
20130108620	METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES	2013-05-02
20130108621	ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND THE USE THEREOF IN IMMUNE THERAPIES	2013-05-02
20130108622	DISULFIDE STABILIZED ANTIBODIES AND FRAGMENTS THEREOF	2013-05-02
20130108623	Antibodies with Enhanced or Suppressed Effector Function	2013-05-02
20130108624	CRYPTIC GLYCAN MARKERS AND APPLICATIONS THEREOF	2013-05-02
20130108625	TREATMENT OF MULTIPLE SCLEROSIS (MS)	2013-05-02
20130108626	BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER	2013-05-02
20130108627	HUMANIZED PCRV ANTIBODY HAVING ANTI-PSEUDOMONAL ACTIVITY	2013-05-02
20130108628	Method for treating cancer pain and/or rescuing analgesic effect of morphine treatment of cancer pain	2013-05-02
20130108629	Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof	2013-05-02
20130108630	AMINO ACYL TRNA SYNTHETASES FOR MODULATING INFLAMMATION	2013-05-02
20130108631	METHODS FOR DETECTING ANTIBODIES	2013-05-02
20130108632	Etanercept Formulations Stabilized with Amino Acids	2013-05-02
20130108633	Etanercept Formulations Stabilized with Metal Ions	2013-05-02
20130108634	Etanercept Formulations Stabilized with Meglumine	2013-05-02
20130108635	METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MATRIX MINERALIZATION DISORDERS	2013-05-02
20130108636	HIGH-AFFINITY FULLY FUNCTIONAL SOLUBLE SINGLE-DOMAIN HUMAN CD4, ANTIBODIES, AND RELATED FUSION PROTEINS	2013-05-02
20130108637	THERAPEUTIC AGENT FOR FIBROMYALGIA CONTAINING ETANERCEPT	2013-05-02
20130108638	ANTAGONIST ANTIBODIES AGAINST EPHB3	2013-05-02
20130108639	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER	2013-05-02
20130108640	ANTIKINE ANTIBODIES THAT BIND TO MULTIPLE CC CHEMOKINES	2013-05-02
20130108641	ANTI-GITR ANTIBODIES	2013-05-02
20130108642	IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH	2013-05-02
20130108643	METHOD TO TREAT AUTOIMMUNE DEMYELINATING DISEASES AND OTHER AUTOIMMUNE OR INFLAMMATORY DISEASES	2013-05-02
20130108644	Inhibition of AXL Signaling in Anti-Metastatic Therapy	2013-05-02

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees